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ON IFNγ LEVEL OF MULTIBACILLARY LEPROSY PATIENTS RECEIVING WHO-MDT 
1)Primasthi Anggraeni , R.Sri Djoko Susanto, Meilien Himbawani, Retno Indar Widayati
PENGARUH SUPLEMENTASI JINTEN HITAM TERHADAP KADAR IFN-γ KUSTA TIPE MB
YANG MENDAPAT TERAPI MDT-WHO
ABSTRAK
Latar belakang: Interferon-γ merupakan sitokin pengaktivasi makrofag utama, berfungsi penting dalam pertahanan alamiah dan 
imunitas seluler terhadap mikroba intraseluler seperti M. leprae. Beberapa penelitian menunjukkan bahwa Jinten Hitam dapat 
meningkatkan produksi IFNγ, memiliki efek potensiasi terhadap sistem imunitas seluler dan efek stimulasi terhadap sel Th1 serta 
memiliki efek inhibisi terhadap sel Th2. Studi ini bertujuan mengetahui pengaruh suplementasi jinten hitam terhadap kadar IFNγ kusta 
tipe MB yang mendapat terapi MDT-WHO.
Metode: studi eksperimental dengan desain randomized controlled trial. Sebanyak 44 pasien kusta MB dikelompokkan menjadi 2 
kelompok: (i) kelompok plasebo, yang mendapatkan MDT-WHO dan plasebo, (ii) kelompok Jinten Hitam, yang mendapatkan MDT-
WHO dan Jinten Hitam. Variabel independen adalah pemberian MDT-WHO dan Jinten hitam serta MDT-WHO dan plasebo, yang 
diberikan selama 2 bulan. Variabel dependen adalah kadar IFNγ. 
Hasil: Rata-rata kadar IFNγ sebelum dan sesudah perlakuan pada kelompok jinten hitam secara statistik berbeda bermakna (p<0,0001) 
dan  rata-rata nilai delta kadar IFNγ pada kelompok jinten hitam juga secara signifikan lebih tinggi (p<0,05) dibanding plasebo.
Simpulan: Suplementasi dengan ekstrak Jinten Hitam dapat meningkatkan kadar IFNγ pada pasien kusta tipe multibasiler (MB).
Kata kunci: Ekstrak Jinten Hitam, nigella sativa, lepra multibasiler, IFNγ
ABSTRACT
Background: Several studies showed that black seeds enhanced the production of IFN γ, posses potent potentiating effects on the CMI/ stimulatory 
effect on Th1 cells, while posses suppressor effects on humoral immunity/ inhibitory effect on Th2 cells.The purpose of this study is to know the effects 
of black seeds extract supplementation on IFN γ level of multibacillary leprosy patientswho received MDT-WHO therapy.
Methods: This study is experimental research with randomized controlled trial design. A sample of 44 patients was randomized into 2 groups: (i) 
placebo group, receiving WHO-MDT  and placebo, (ii) black seed goup, receiving WHO-MDT and black seed extracts. The independent variable was 
the WHO-MDT plus black seed supplementation (3000 mg), and WHO-MDT plus placebo given for 2 months . The dependent variable was IFN γ 
level.
Results: Mean level of IFN γ before and after study from black seed groups was significantly different (p<0,0001), and mean delta value of black seed 
group was significantly superior (p=0,005/ p<0,05) to that of placebo.
Conclusion: Supplementation with black seeds extracts can enhance IFNγ production of multibacillary leprosy patients.
Key words : MB Leprosy, Black seeds extract, Nigella sativa, IFN-γ
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Interferon is the principal macrophage- 
activating cytokine and serves critical functions in 
immunity against intracellular microbes, including 
M.leprae. Interferon enhances production of reactive 
oxygen species and nitrogen intermediates by 
macrphage dan indusce macrophage to kill and 
limiting intracelluler pathogen growth. Interferon 
involved in the formation of granulomas containing 
well-differentiated, bactericidal macrophages that 
play an essential role in preventing the extension 
and dissemination of mycobacterial infections. The 
protective functions of IFN γ has been emphasized 
in several reports that describe the deleterious effect 
of mutation and deletions in IFN γ genes and their 
receptors on mycobacterial infections.
Seeds of Nigella sativa/black seed, which 
belongs to Ranunculaceae family already well known 
and widely used in traditional medicines. One of the 
precious properties of black seeds is the 
immunomodulatory effects of its constituents. 
Several studies showed that black seeds enhanced 
the production of IFN γ, posses potent potentiating 
effects on the CMI/ stimualtory effect on Th1 cells, 
while posses suppressor effects on humoral 
immunity/ inhibitory effect on Th2 cells
The relationship between black seeds extract 
supplementation and  IFN γ level of multibacillary 
leprosy patients is still unknown. Therefore, in the 
present study the effect of black seeds extract 
supplementation on IFN γ level of multibacillary 
leprosy patients is examined.
METHODS
The study design was experimental research 
with randomized controlled trial design. A sample 
of 44 patients was randomized into 2 groups. They 
were selected by consecutive sampling and 
subjected to the double blind treatment. All patients 
received the standard WHO-MDT regimen for 
leprosy, while 1 group received black seeds 
supplementation and another group received 
placebo. Standard drug used was WHO multidrug 
therapy, while black seeds used in this study were 
manufactured and standardized by the 
pharmaceutical industry Habasa Al-Afiat, 
Indonesia. Inclusion criterias were newly 
diagnosed multibacillary leprosy patients or no 
longer than  3 months on multidrug therapy, not 
having systemic, autoimmune or other infection 
INTRODUCTION
Leprosy is a chronic infectious disease that can 
cause deformities, disabilities and stigmatism.  The 
use of Multidrug therapy (MDT) had lower the 
global prevalence from 5,2 million in the 1980s to 
200.000 in 2014. However, the new case detection 
rate remains high; which around 220.000–250.000 
people have been diagnosed with leprosy each 
year.Indonesia is the third country with the highest 
leprosy case following India and Brazil. Another  
strategies might be needed beside early detection 
and multidrug therapy. Nowadays, review and 
study of micronutrients impact in leprosy are 
developed to achieve better clinical outcomes 
related to treatment response and preventing 
household contact from developing infection.
Quality and quantity of cytokines are critical in 
initiation and excecution of immunity. Excessive or 
insufficient production of cytokines may 
significantly contributeto the pathophysiology of a 
range of disease responses and are thought to be 
decisive for pathological or physiological 
consequences. After activation, CD4 T helper cells 
differentiate into their Th1 type cells, secreting IL- 2, 
IL-12, IFN-γ and TNFα, or Th2 type cells, secreting 
IL-4, IL-5, IL-10 and IL-13. Indeed, the balance 
between Th1 and TH2 cytokines is critical for the 
orientation of the inflammatory responses toward 
cell- mediated or humoral-mediated responses. 
Thus, any factors that can interfere with Th1/Th2 
axis might affect the outcome of the response.
Leprosy has clinical manifestation spectrum 
related to host immune response against M.leprae. 
Its characterized by two polar  disease form. In polar 
tuberculoid leprosy  there is a strong cell mediated 
immune response (CMI) which limits the disease to 
a few lesions with little evidence of bacilli. Th1 
cytokine like TNFα and IFN-γ are expressed 
stronger in tuberculoid pole/pausibacillar 
spectrum. In contrast, at another spectrum 
(lepromatous pole), patients exhibit a defective CMI 
response to M. leprae there by causing a high 
bacillary load and lots of skin lesions, making 
untreated multibacillary patients becoming main 
reservoir and transmission of M.leprae. Th2 
cytokines like IL-4, IL-5 and IL-10 elevated anc 
becoming characteristic of lepromatous or 
multibacillar patiens, with low level of Th1 
cytokines, including IFN-γ.
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and palcebo, (ii) black seed goup, receiving WHO-
MDT and black seed extracts.  Both group consist of 
15 men and 7 women each. Mean age of black seed 
group was 37±14 years with a range from 18 to 64, 
while placebo group  was 43±12 years with a range 
from 18 to 60. The level of education of black seed 
group was not educated in 4 (18.2%), elementary 
school in 11 (50%), junior high school in 5 (22.7%) 
and senior high school in 2 (9.1%) patients, while 
placebo group was not educated in 3 (13.6%), 
elementary school in 15 (68.2%), junior high school 
in 3 (13.6%) and senior high school in 1 (4.5%) 
patients. The mean body mass index  (BMI) of black 
seed group was  19.93±3.46 and placebo group was 
19.53±2.41 . Family history of leprosy was 
positive in 20 (90.9%) patients from black seed 
groups and 19 (86.4 %) in palcebo groups. There was 
no significant difference in those characteristic 
between two groups.
Mean level of IFN γ before and after study from 
black seed groups was significantly different 
(p<0.0001), which mean level of IFN γ before study 
was 4.24 pg/ml and after study was 7.57 pg/ml 
(table 1?)
disease, noton any immunosuppresan or 
immunomodulator drugs/supplement and were 
willing to sign informed consent. Exclution criteria 
were patients on reactional states or pregnancy.
The independent variable was the WHO-MDT 
plus black seed supplementation (3000 mg), 
andWHO-MDT plus placebo given for 2 months. 
The dependent variable was IFN γ level .
Analysis of the data was calculated by using 
SPSS (SPSS Inc, Chicago, IL) to know the 
differenceslevel of IFNγ serum before and after the 
study. A p value less than 0.05 was considered 
significant. Approval of the Medical Ethic 
Committees was obtained before the start of the 
s t u d y  
. Only patients who had given 
informed consent were included in the study.
RESULTS
Fourty two patients met the inclusion criteria 
were collected.  Those patients were divided into 2 
groups, (i) placebo group, receiving WHO-MDT  
( s e b u t k a n  E t h i c a l  C l e a r a n c e  
No......./.../....???)
Table 1. Characteristic data regarding gender, age, education and body mass index 
variable
Gender
Black seeds group
n (%) Mean ± SD Median
(Min-max)
Placebo group
n (%) Mean ± SD Median
(Min-max)
p
Male
Female
15 (68.2)
7 (31.8)
15 (68.2)
7 (31.8)
a
1.00
Age 37 ± 14.0 43 ± 12.0 45 (18–60)35 (18–64)
Education level
Uneducated
Elementary 
school
4 (18.2)
11 (50.0)
3 (13.6)
15 (68.2)
a
0.661
Junior high
school
Senior high
school
5 (22.7)
2 (9.1)
3 (13.6)
1 (4.5)
Body mass 
index
Underweight
Normoweight
6 (27.3)
16 (72.7)
9 (40.9)
12 (54.5)
Overweight
Obese
0 (0.0)
0 (0.0)
1 (4.5)
0 (0.0)
Family history with leprosy
Positive
Negative
20 (90.9)
2 (9.1)
19 (86.4)
3 (13.6)
a
1.000
b
0.65619.21
(16.61–26.16)
19.53 ± 2.4120.20
(10.94–24.44)
19.93 ± 3.46
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significant differences between IFNγ level before 
and after study from black seed extract groups. We 
also found significant differences on delta IFNγ 
level between black seeds extract and placebo 
groups.
The effect of black seed extracts on IFNγ level of 
multibacillary leprosy patients has not been studied 
previously. One proposed mechanism of action 
from black seed extracts is its regulation of Th1 and 
Th2 balance. Some study  found that black seeds 
extracts posses potent potenstiating effects on the 
cellular (T cell-meditaed) immunity, while posses 
suppressor efects on B cell-mediated (humoral) 
immunity. Study by Boskabady (2011) on effect of 
black seed extracts on ovalbumin sensitized guinea 
pigs  found that the black seed extracts enhanced the 
production of IFNγ and caused inhibitoy effect on 
IL-4, indicating the inhibitory effect on Th2 cells and 
stimulatory effect on Th1 cells. The effect of black 
seed oil on murine cytomegalovirus infection 
showed the most striking inhibition of virus titers in 
the spleen and liver which was showed by 
undetectable virus titer on day-10 and an increase in 
the serum level of IFNγ. Study of black seeds' 
adjuvant effects to improve allergic rhinitis patients 
showed statistically significant increase in the 
phagocytic and intracellular killing activities of 
PMNs. El Gazzar et al (2006) also examined effect of 
black seed in mouse model of allergic lung 
inflammation which showed a marked decrease in 
Th2 cytokines in black seeds terated sensitized mice. 
In leprosy, the quality and quantity of the innate 
and adaptive immune response determine the 
outcome of infection; whereas the pro inflammatory 
cytokine IFNγ provides protection against 
mycobacteria, the anti-inflammatory cytokines IL-
10 has been showd to be associated with dampening 
Th1 cells' responses toward mycobacteria. Thus, 
changes in the IFNγ/IL-10 ratio may provide 
information about potential disease development or 
response to treatment. It is hoped that black seeds 
extract supplementation on multibacillary leprosy 
patienst receiving WHO-MDT can inprove disease 
prognostic and lower disease transmission risk by 
increasing patients' low cellular immunity.
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